Skip to Content
Merck
CN
  • Development of orally bioavailable bicyclic pyrazolones as inhibitors of tumor necrosis factor-a production.

Development of orally bioavailable bicyclic pyrazolones as inhibitors of tumor necrosis factor-a production.

Journal of Medicinal Chemistry (2004)
Clark MP, et al.